Day | Jotup

Ocean Drive Plastic Surgery's Dr. Alan Durkin to Present Clinical Research on Bellafill at the 12th Chinese Annual Meeting of Minimally-Invasive Aesthetic Medicine

Retrieved on:

星期三, 五月 8, 2024

Education, Patient, NMPA, National Medical Products Administration, Day, Drive, MD, Conference, Knowledge, Plastic

Dr. Durkin will showcase his vast clinical expertise with Bellafill, symbolizing a monumental milestone for both Suneva and the global aesthetic industry.

Key Points:

Dr. Durkin will showcase his vast clinical expertise with Bellafill, symbolizing a monumental milestone for both Suneva and the global aesthetic industry.
Suneva's journey to introduce Bellafill to the Chinese market has been marked by dedication and commitment.
After an extensive five-year process, Suneva received approval from the National Medical Products Administration (NMPA) in China on January 17, 2024.
With over sixty peer-reviewed articles and six book chapters on aesthetic medicine and surgery, Dr. Durkin's expertise will undoubtedly enrich the discourse at the MIAM conference.

VSS Capital Partners Portfolio Company Olympus Cosmetic Group Completes Acquisition of Artisan

Retrieved on:

星期三, 五月 8, 2024

VSS Capital Partners (“VSS”), a private investment firm investing in the healthcare, business services, and education industries, today announced that its portfolio company, Olympus Cosmetic Group (“Olympus”), a platform providing comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures, has completed the acquisition of Artisan Plastic Surgery and Artisan Beauté (collectively “Artisan” or the “Company”), a female-founded and managed cosmetic surgery and medspa enterprise.

Key Points:

VSS Capital Partners (“VSS”), a private investment firm investing in the healthcare, business services, and education industries, today announced that its portfolio company, Olympus Cosmetic Group (“Olympus”), a platform providing comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures, has completed the acquisition of Artisan Plastic Surgery and Artisan Beauté (collectively “Artisan” or the “Company”), a female-founded and managed cosmetic surgery and medspa enterprise.
While financial terms of the transaction were not disclosed, VSS made an additional investment to support Olympus’ first acquisition.
“The team at Artisan is aligned seamlessly with Olympus Cosmetic Group’s mission to deliver quality and expertly performed cosmetic procedures to patients.
McDermott Will & Emery provided counsel to VSS and Olympus Cosmetic Group.

"Daytime Stands Up" Livestream Event, Featuring the Stars of Daytime Drama, to Raise Funds for Cancer Research

Retrieved on:

星期四, 五月 2, 2024

LOS ANGELES, May 2, 2024 /PRNewswire/ -- On Thursday, May 16, Stand Up To Cancer® (SU2C), in collaboration with leading daytime community voices Alan Locher and Michael Fairman, will come together for a first-of-its-kind livestream event, Daytime Stands Up: A Benefit for Stand Up To Cancer … We All Have a Story. The three-hour benefit will feature stars from the world of daytime drama television past and present, musical performances, and stories of emotional on- and off-screen experiences with cancer. Special celebrity guests will also join the effort to encourage viewers to support urgently needed research and new cancer treatments.

Key Points:

The three-hour benefit will feature stars from the world of daytime drama television past and present, musical performances, and stories of emotional on- and off-screen experiences with cancer.
Special celebrity guests will also join the effort to encourage viewers to support urgently needed research and new cancer treatments.
"Daytime television invites viewers into the private lives of characters, often bringing important issues like cancer screenings into living rooms and around water coolers.
"Today, it's become almost impossible to avoid; but there is hope with cancer research, thanks to organizations like Stand Up To Cancer."

A SIZZLING SUMMER AWAITS: OMNI SERVES UP EPIC 'THESE ARE THE DAYS' EXPERIENCES

Retrieved on:

星期二, 四月 30, 2024

Spend, System, Omni Hotels & Resorts, Meal, These Are the Days, Travel, Collection, Citrus, Life, Family, Golf, Day, Tourism

DALLAS, April 30, 2024 /PRNewswire/ -- Now more than ever travelers are prioritizing experiences over material possessions, craving authentic, immersive encounters that allow them to connect with local culture and communities. This summer, Omni Hotels & Resorts is rolling out an exclusive array of Signature Experiences that will be relived by its guests for years to come. Omni underscores its dedication to crafting lasting memories with the launch of the new "These are the Days" program at its expansive collection of over 50 hotels and resorts.

Key Points:

This summer, Omni Hotels & Resorts is rolling out an exclusive array of Signature Experiences that will be relived by its guests for years to come.
"These are the times you'll look back on as the best in your life, and Omni is the place that will ensure you remember them.
Furthermore, all Omni properties will celebrate their destinations through nightly rituals this summer.
As an added perk this summer, kids 10 and under eat all meals free when staying with Select Guest members.

Ocean Drive Plastic Surgery Founder Dr. Alan Durkin Appointed VIO Med Spa Chief Medical Officer

Retrieved on:

星期三, 四月 17, 2024

Hospital, Biologic, MTF, Day, Elective surgery, Florida State University, VIO, Patient, Medical director, Growth, Plastic, Plastic and Reconstructive Surgery, Dentistry

VERO BEACH, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Ocean Drive Plastic Surgery, Dermatology, and MedSpa , the premier aesthetic surgery center on Florida’s Treasure Coast, today announced that dual Board-Certified Plastic & Reconstructive Surgeon and Owner/Founder of Ocean Drive Plastic Surgery, Dermatology, and MedSpa and Founder and Medical Director of MedSpa Network, Dr. Alan Durkin has been appointed Chief Medical Officer of innovative aesthetic and wellness franchise company, VIO Med Spa .

Key Points:

VERO BEACH, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Ocean Drive Plastic Surgery, Dermatology, and MedSpa , the premier aesthetic surgery center on Florida’s Treasure Coast, today announced that dual Board-Certified Plastic & Reconstructive Surgeon and Owner/Founder of Ocean Drive Plastic Surgery, Dermatology, and MedSpa and Founder and Medical Director of MedSpa Network, Dr. Alan Durkin has been appointed Chief Medical Officer of innovative aesthetic and wellness franchise company, VIO Med Spa .
As Chief Medical Officer for VIO Med Spa, Dr. Durkin will lead a team of medical directors, each heading their own franchise units, as they deliver exceptional pre- and post-care to VIO Med Spa franchise patients.
A distinguished plastic & reconstructive surgeon, Dr. Durkin brings a portfolio of notable achievements and experience to his position with VIO Med Spa.
Dr. Durkin adds this position to his list of expert credentials including founder and aesthetic plastic surgeon with Ocean Drive Plastic Surgery, Ocean Drive Dermatology and Ocean Drive MedSpa; founder and Medical Director of the MedSpa Network; Chairman of Plastic and Reconstructive Surgery at Cleveland Clinic Indian River Hospital; Vice Chairman of the Department of Surgery at Cleveland Clinic Indian River; and Clinical Assistant Professor of Plastic Surgery at Florida State University, and Larkin Medical Center.

New Nextech Med Spa for Wellness and Weight Loss Software Increases Average Patient Encounter Revenue by 70%

Retrieved on:

星期三, 四月 10, 2024

Massage, Health, Software, Wellness, Weight loss, Day, Beauty salon

"Med spas have been forced to choose between software built for massage spas or hair salons neither of which is right for a med spa,” said Nextech CEO Bill Lucchini.

Key Points:

"Med spas have been forced to choose between software built for massage spas or hair salons neither of which is right for a med spa,” said Nextech CEO Bill Lucchini.
Now, we’ve made it easy to tap into the huge market for weight loss treatment."
Nextech Med Spa is a single solution with a full suite of tools providing med spa owners and staff with end-to-end visibility and management capabilities.
Based on average spend per patient visit of $536 as reported in the "The 2022 Medical Spa State of the Industry Report" by The American Medical Spa Association and on Nextech data.

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

Retrieved on:

星期三, 四月 10, 2024

DOYLESTOWN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today released details about four poster presentations at the ongoing American Association of Cancer Research (AACR) Annual Meeting, taking place April 5 to 10, 2024 in San Diego, CA. The posters feature APR-1051, Aprea’s next-generation inhibitor of WEE1 kinase, as well as a clinical update on ATRN-119, its novel macrocyclic ATR inhibitor. The Company also presented a poster highlighting a new set of preclinical data in glioblastoma with a next-generation macrocyclic ATR inhibitor, ATRN-333.

Key Points:

Part 1 will be dose escalation and is expected to enroll up to 39 patients with advanced solid tumors harboring cancer-associated gene alterations.
ATRN-119 continues to be safe and well tolerated, with no dose-limiting toxicities and no signs of significant hematological toxicity reported.
Pharmacokinetic studies show ATRN-119 serum concentrations are entering the expected therapeutic range at the current highest dose level (550 mg).
Convection-enhanced delivery of a novel ATR inhibitor synergizes with systemic lomustine for improved treatment of glioblastoma.

Calamos Targets Capital Protected Industry with 12 New ETFs Delivering 100% Downside Protection, Growth Potential & Tax-Alpha

Retrieved on:

星期一, 四月 22, 2024

Calamos Investments LLC, referred to herein Calamos is a financial services company offering such services through its subsidiaries: Calamos Advisors LLC, Calamos Wealth Management LLC, Calamos Investments LLP, and Calamos Financial Services LLC.

Key Points:

Calamos Investments LLC, referred to herein Calamos is a financial services company offering such services through its subsidiaries: Calamos Advisors LLC, Calamos Wealth Management LLC, Calamos Investments LLP, and Calamos Financial Services LLC.
An investment in the Fund(s) is subject to risks, and you could lose money on your investment in the Fund(s).
*The Calamos Russell 2000 Structured Alt Protection ETFs are currently reflected in an initial SEC filing under the name Calamos Capital Protected Russell 2000 ETFs.
Calamos® and Calamos Investments® are registered trademarks of Calamos Investments LLC.

Nuvei launches Invoice Financing to unlock merchant cash flow

Retrieved on:

星期四, 四月 11, 2024

DSO, ERP, TSX, Acumatica, ERPs, Day, Sage, Growth, Invoice, Bookkeeping

MONTREAL, April 11, 2024 /PRNewswire/ -- Nuvei Corporation (Nasdaq: NVEI) (TSX: NVEI), the Canadian fintech company, today announces the launch of its new Invoice Financing services that have been integrated into several leading enterprise resource planning (ERP) platforms, including Sage and Acumatica. This new service enables merchants to access Nuvei's Invoice Financing solutions directly within their ERP systems to optimize cash flow and unlock working capital more efficiently.

Key Points:

This new service enables merchants to access Nuvei's Invoice Financing solutions directly within their ERP systems to optimize cash flow and unlock working capital more efficiently.
Invoice Financing from Nuvei ensures that businesses not only receive the cash they need promptly, but they also benefit from uniquely favorable rates made available by existing payment transaction data.
Enhanced cash flow management: With one-click invoice financing seamlessly integrated into the ERP, businesses can maintain a healthier cash flow by converting outstanding invoices into immediate working capital.
"By integrating our Invoice Financing services with leading ERP platforms, we're empowering businesses to unlock financial flexibility and optimize their cash flow management, ultimately supporting their success in the ever-evolving business landscape."

MD Esthetics Announces Expansion Outside of New England

Retrieved on:

星期五, 四月 5, 2024

Health, Weight loss, Female, Acquisition, MD, Wellness, Day, Aesthetics

WINDHAM, N.H., April 4, 2024 /PRNewswire/ -- MD Esthetics is excited to announce the acquisition of three new locations.

Key Points:

WINDHAM, N.H., April 4, 2024 /PRNewswire/ -- MD Esthetics is excited to announce the acquisition of three new locations.
MD Esthetics, LLC is a premier medical aesthetics brand comprising ten corporate and one franchisee-owned location.
Adding on to the existing portfolio of locations in New England is the acquisition of Marino Health and Wellness in Londonderry, NH.
According to MD Esthetics COO Danielle Pedro "The team at Marino has built a strong business focused on wellness, pain-management, female health, and weight loss.